CABG surgery

PROCEDURE5 trials

Sponsors

Yonsei University, Helsinki University Central Hospital, University of Miami, Maharajgunj Medical Campus, HELP Therapeutics Co., Ltd.

Conditions

CABGCardiomyopathy, DilatedCoronary Artery DiseaseHeart Failure

Phase 3

A Pivotal Clinical Trial of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advanced Heart Failure(NYHA III-IV)

RecruitingNCT07496372

HELP Therapeutics Co., Ltd.Heart Failure

Start: 2026-04-30End: 2027-08-31Target: 80Updated: 2026-05-12

Unknown Phase

Current Treatment Strategy of Patients With Multivessel Disease or Left Main Coronary Artery Disease Indicated for Coronary Artery Bypass Graft Surgery

Yonsei UniversityCoronary Artery Disease

Start: 2015-04-30End: 2020-03-31Target: 2500Updated: 2018-07-17

Autologous Atrial Appendage Derived Cells in the Treatment of Heart Failure

CompletedNCT02672163

Helsinki University Central HospitalHeart Failure

Start: 2016-02-29End: 2019-12-31Updated: 2020-03-05

Ventricular Sling for Heart Failure With Reduced Ejection Fraction

WithdrawnNCT04475315

University of MiamiCardiomyopathy, Dilated, Heart Failure

Start: 2021-12-12End: 2027-12-31Updated: 2022-05-11

Incidence and Risk Factors of Surgical Site Infections After Coronary Artery Bypass Grafting Surgery

CompletedNCT07130422

Maharajgunj Medical CampusCABG

Start: 2023-07-01End: 2024-06-01Updated: 2025-08-19

Related Papers

Epicardial Transplantation of Autologous Cardiac Micrografts During Coronary Artery Bypass Surgery

Frontiers in Cardiovascular Medicine2021-09-1412 citations

Epicardial delivery of autologous atrial appendage micrografts during coronary artery bypass surgery-safety and feasibility study.

2017-12-2014 citations